SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults: Therapeutic Options and Challenges in 2023

被引：0

作者：

Rahman, Zaid Abdel ^{[1
]}

Kebriaei, Partow ^{[1
,2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Div Canc Med, 1515 Holcombe Blvd, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷 / 11期

关键词：

Acute lymphoblastic leukemia; Transplantation; Tyrosine kinase inhibitor; Imatinib; Dasatinib; Nilotinib; Ponatinib; Blinatumomab; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; TERM-FOLLOW-UP; TYROSINE KINASE INHIBITORS; CHEMOTHERAPY PLUS DASATINIB; LOW-INTENSITY CHEMOTHERAPY; PHASE-II; B-CELL; MOLECULAR RESPONSE; ELDERLY-PATIENTS;

D O I：

10.1016/j.clml.2023.06.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The therapeutic landscape of Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) for adults has dramatically changed over the past 2 decades; the emergence of newer generations of tyrosine kinase inhibitors and incorporation of targeted immunotherapies into front-line therapy have significantly improved outcomes to the point where an argument can be made that this entity may no longer be considered a high-risk ALL subgroup. In this review article, we discuss different front-line regimens (both intensive and deintensified regimens including chemotherapyfree regimens). We also review disease monitoring strategies, discuss the role of allogeneic hematopoietic stem cell transplantation, and discuss the rapidly changing therapeutic landscape for patients with relapsed disease.

引用

页码：779 / 785

页数：7

共 73 条

[1] Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Akahoshi, Yu ;

Nishiwaki, Satoshi ;

Mizuta, Shuichi ;

Ohashi, Kazuteru ;

Uchida, Naoyuki ;

Tanaka, Masatsugu ;

Fukuda, Takahiro ;

Ozawa, Yukiyasu ;

Takahashi, Satoshi ;

Onizuka, Makoto ;

Shiratori, Souichi ;

Nakamae, Hirohisa ;

Kanda, Yoshinobu ;

Ichinohe, Tatsuo ;

Atsuta, Yoshiko ;

Kako, Shinichi .

CANCER SCIENCE, 2019, 110 (10) :3255-3266

[2] Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia [J].

Assi, Rita ;

Kantarjian, Hagop ;

Short, Nicholas J. ;

Daver, Naval ;

Takahashi, Koichi ;

Garcia-Manero, Guillermo ;

DiNardo, Courtney ;

Burger, Jan ;

Cortes, Jorge ;

Jain, Nitin ;

Wierda, William ;

Chamoun, Salim ;

Konopleva, Marina ;

Jabbour, Elias .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12) :897-901

[3] More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling [J].

Bader, Peter ;

Salzmann-Manrique, Emilia ;

Balduzzi, Adriana ;

Dalle, Jean-Hugues ;

Woolfrey, Ann E. ;

Bar, Merav ;

Verneris, Michael R. ;

Borowitz, Michael J. ;

Shah, Nirali N. ;

Gossai, Nathan ;

Shaw, Peter J. ;

Chen, Allen R. ;

Schultz, Kirk R. ;

Kreyenberg, Hermann ;

Di Maio, Lucia ;

Cazzaniga, Gianni ;

Eckert, Cornelia ;

van der Velden, Vincent H. J. ;

Sutton, Rosemary ;

Lankester, Arjan ;

Peters, Christina ;

Klingebiel, Thomas E. ;

Willasch, Andre M. ;

Grupp, Stephan A. ;

Pulsipher, Michael A. .

BLOOD ADVANCES, 2019, 3 (21) :3393-3405

[4] Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00 [J].

Bassan, Renato ;

Rossi, Giuseppe ;

Pogliani, Enrico M. ;

Di Bona, Eros ;

Angelucci, Emanuele ;

Cavattoni, Irene ;

Lambertenghi-Deliliers, Giorgio ;

Mannelli, Francesco ;

Levis, Alessandro ;

Ciceri, Fabio ;

Mattei, Daniele ;

Borlenghi, Erika ;

Terruzzi, Elisabetta ;

Borghero, Carlo ;

Romani, Claudio ;

Spinelli, Orietta ;

Tosi, Manuela ;

Oldani, Elena ;

Intermesoli, Tamara ;

Rambaldi, Alessandro .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3644-3652

[5] 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation [J].

Bazarbachi, Ali ;

Labopin, Myriam ;

Aljurf, Mahmoud ;

Niittyvuopio, Riitta ;

Balsat, Marie ;

Blaise, Didier ;

Yakoub-Agha, Ibrahim ;

Grassi, Anna ;

Reinhardt, Hans Christian ;

Lenhoff, Stig ;

Jindra, Pavel ;

Passweg, Jakob ;

Abou Dalle, Iman ;

Stadler, Michael ;

Lioure, Bruno ;

Ceballos, Patrice ;

Brissot, Eolia ;

Giebel, Sebastian ;

Nagler, Arnon ;

Schmid, Christoph ;

Mohty, Mohamad .

CLINICAL CANCER RESEARCH, 2022, 28 (05) :1004-1012

[6] Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia AMeta-analysis [J].

Berry, Donald A. ;

Zhou, Shouhao ;

Higley, Howard ;

Mukundan, Lata ;

Fu, Shuangshuang ;

Reaman, Gregory H. ;

Wood, Brent L. ;

Kelloff, Gary J. ;

Jessup, J. Milburn ;

Radich, Jerald P. .

JAMA ONCOLOGY, 2017, 3 (07)

[7] Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia [J].

Brissot, Eolia ;

Labopin, Myriam ;

Beckers, Marielle M. ;

Socie, Gerard ;

Rambaldi, Alessandro ;

Volin, Liisa ;

Finke, Juergen ;

Lenhoff, Stig ;

Kroeger, Nicolaus ;

Ossenkoppele, Gert J. ;

Craddock, Charles F. ;

Yakoub-Agha, Ibrahim ;

Gurman, Gunhan ;

Russell, Nigel H. ;

Aljurf, Mahmoud ;

Potter, Michael N. ;

Nagler, Armon ;

Ottmann, Oliver ;

Cornelissen, Jan J. ;

Esteve, Jordi ;

Mohty, Mohamad .

HAEMATOLOGICA, 2015, 100 (03) :392-399

[8] Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia [J].

Chen, Huan ;

Liu, Kai-yan ;

Xu, Lan-ping ;

Liu, Dai-hong ;

Chen, Yu-hong ;

Zhao, Xiang-yu ;

Han, Wei ;

Zhang, Xiao-hui ;

Wang, Yu ;

Zhang, Yuan-yuan ;

Qin, Ya-zhen ;

Liu, Yan-rong ;

Huang, Xiao-jun .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5

[9]

Chiaretti S BR, 2021, EUROPEAN HEMATOLOGY

[10] Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Daver, Naval ;

Thomas, Deborah ;

Ravandi, Farhad ;

Cortes, Jorge ;

Garris, Rebecca ;

Jabbour, Elias ;

Garcia-Manero, Guillermo ;

Borthakur, Gautam ;

Kadia, Tapan ;

Rytting, Michael ;

Konopleva, Marina ;

Kantarjian, Hagop ;

O'Brien, Susan .

HAEMATOLOGICA, 2015, 100 (05) :653-661

← 1 2 3 4 5 6 7 8 →